\-\ Texto\\:\\ \ \(0\)\
\-\ regular\\ prophylactic\\ antibiotics\\ and\\ regular\\ f\\/u\\ with\\ pediatric\\ urology\ \(0\)\
\-\ u\\/s\\:\ \(0\)\
\-\ r\\ kidney\\:\\ demonstrating\\ normal\\ echogenicity\\ and\\ measuring\\ 9\\.5cm\\ \\(upper\\ limit\\ of\\ normal\\ for\\ patient\\ age\\.\\)\\ there\\ is\\ no\\ evidence\\ of\\ hydronephrosis\ \(0\)\
\-\ l\\ kidney\\:\\ elongated\\ measuring\\ 11\\.5cm\\.\\ there\\ is\\ evidence\\ of\\ mild\\ hyperechogenecity\\ of\\ the\\ renal\\ cortex\\.\ \(0\)\
\-\ vcug\\:\\ grade\\ ii\\ reflux\\ on\\ the\\ right\\.\\ grade\\ iv\\ reflux\\ on\\ the\\ left\\ with\\ mild\\ tortuosity\\ of\\ the\\ ureter\\.\\ additionally\\,\\ there\\ are\\ compound\\ calyces\\ of\\ the\\ superior\\ and\\ inferior\\ poles\\ of\\ the\\ left\\ collecting\\ system\\.\\ normal\\ urethra\\ without\\ evidence\\ of\\ posterior\\ urethral\\ valves\\ \\(puv\\)\\.\ \(0\)\
\-\ vesicoureteral\\ reflux\ \(36\)\
\-\ previously\\ healthy\\ 4yo\\ male\\ with\\ a\\ recent\\ history\\ of\\ decreased\\ appetite\\ and\\ approximately\\ 5lb\\ weight\\ loss\\ x\\ 2\\.5wks\\,\\ intermittent\\ vomiting\\ and\\ diarrhea\\ x\\ 2wks\\,\\ and\\ dysuria\\ x\\ 2d\\ presents\\ with\\ fever\\ to\\ 104\\,\\ mild\\ tachycardia\\,\\ and\\ cvat\\ l\\>r\\.\\ initial\\ lab\\ work\\-up\\ reveals\\ increased\\ wbc\\ and\\ the\\ presence\\ of\\ urine\\ nitrites\\ and\\ leukocyte\\ esterase\\.\ \(0\)\
\-\ definition\\:\\ vesioureteral\\ reflux\\ \\(vur\\)\\ describes\\ a\\ process\\ in\\ which\\ there\\ is\\ retrograde\\ passage\\ of\\ urine\\ from\\ the\\ bladder\\ into\\ the\\ upper\\ urinary\\ tract\\.\\ vur\\ can\\ be\\ divided\\ into\\ two\\ categories\\ \\-\\ primary\\ and\\ secondary\\.\\ primary\\ vur\\ is\\ caused\\ by\\ a\\ congenital\\ anomaly\\ of\\ the\\ ureterovesical\\ junction\\ \\(uvj\\)\\ such\\ as\\ a\\ shortened\\ intravesical\\ ureter\\ or\\ an\\ ectopic\\ ureteral\\ opening\\ in\\ the\\ bladder\\ trigone\\.\\ secondary\\ vur\\ is\\ caused\\ by\\ increased\\ intravesical\\ pressure\\ most\\ likely\\ caused\\ by\\ obstruction\\.\\ obstruction\\ could\\ be\\ anatomic\\ \\(such\\ as\\ in\\ posterior\\ urethral\\ valves\\)\\ or\\ functional\\ \\(such\\ as\\ voiding\\ or\\ bladder\\ abnormalities\\)\\ \ \(0\)\
\-\ epidemiology\\:\\ vur\\ is\\ found\\ in\\ 1\\%\\ of\\ newborns\\ and\\ is\\ the\\ most\\ common\\ urologic\\ anomaly\\ found\\ in\\ newborns\\.\\ vur\\ is\\ also\\ present\\ in\\ 30\\-45\\%\\ in\\ young\\ children\\ presenting\\ with\\ a\\ febrile\\ uti\\.\\ factors\\ that\\ increase\\ the\\ risk\\ for\\ vur\\ are\\ race\\ \\(caucasian\\:\\ african\\ american\\ \\=\\ 3\\:1\\)\\,\\ gender\\ \\(f\\:m\\ \\=\\ 2\\:1\\)\\,\\ and\\ age\\ \\(increased\\ risk\\ for\\ younger\\ children\\ and\\ infants\\)\\ \ \(0\)\
\-\ diagnosis\\:\\ the\\ definitive\\ diagnosis\\ can\\ only\\ be\\ made\\ by\\ demonstrating\\ reflux\\ of\\ urine\\ from\\ the\\ bladder\\ to\\ the\\ collecting\\ system\\ via\\ vcug\\ or\\ radionuclide\\ cystogram\\.\\ \ \(0\)\
\-\ clinical\\:\\ vur\\ is\\ characteristically\\ discovered\\ during\\ evaluation\\ for\\ childhood\\ uti\\.\\ appox\\ 50\\%\\ of\\ the\\ cases\\ are\\ bilateral\\ at\\ time\\ of\\ discovery\\.\\ \ \(0\)\
\-\ the\\ international\\ reflux\\ study\\ group\\ has\\ established\\ a\\ standardized\\ grading\\ system\\ to\\ describe\\ the\\ severity\\ of\\ vur\\ based\\ on\\ vcug\\ results\\.\\ \ \(0\)\
\-\ grade\\ i\\:\\ ureteral\\ involvement\\ w\\/o\\ dilation\\ \ \(0\)\
\-\ grade\\ ii\\:\\ ureteral\\ and\\ collecting\\ system\\ involvement\\ w\\/o\\ dilation\\ \ \(0\)\
\-\ grade\\ iii\\.\\ mild\\ ureteral\\ and\\ collecting\\ system\\ dilation\\ w\\/\\ mild\\ \ \(0\)\
\-\ calyceal\\ blunting\\ \ \(1\)\
\-\ grade\\ iv\\:\\ grossly\\ dilated\\ ureter\\ and\\ collecting\\ system\\ w\\/\\ \ \(0\)\
\-\ moderate\\ calyceal\\ blunting\\.\\ \ \(1\)\
\-\ grade\\ v\\:\\ massively\\ dilated\\ and\\ tortuous\\ ureter\\ and\\ collecting\\ \ \(0\)\
\-\ system\\.\\ papillary\\ impression\\ no\\ longer\\ visible\\ in\\ \ \(0\)\
\-\ most\\ calyces\\.\\ \ \(1\)\
\-\ despite\\ a\\ high\\ grade\\ of\\ reflux\\,\\ 60\\%\\ of\\ grades\\ iii\\-v\\ reflux\\ will\\ spontaneously\\ resolve\\ by\\ age\\ 4\\.\\ \ \(0\)\
\-\ treatment\\:\\ initial\\ medical\\ treatment\\ consists\\ of\\ long\\-term\\ prophylactic\\ antibiotic\\ therapy\\ to\\ prevent\\ recurrent\\ urinary\\ tract\\ infections\\ and\\ reduce\\ the\\ incidence\\ of\\ long\\-term\\ complications\\ secondary\\ to\\ repeated\\ infections\\ and\\ longstanding\\ reflux\\.\\ \ \(0\)\
\-\ surgical\\ treatment\\ should\\ be\\ considered\\ when\\ there\\ are\\ repeated\\ infections\\ despite\\ prophylactic\\ antibiotics\\,\\ presence\\ of\\ a\\ ureterocele\\,\\ presence\\ of\\ urinary\\ tract\\ obstruction\\,\\ or\\ if\\ reflux\\ does\\ not\\ resolve\\ past\\ the\\ age\\ of\\ 4\\-5yo\\.\\ currently\\,\\ there\\ are\\ two\\ surgical\\ options\\ \\-\\ open\\ surgical\\ reimplantation\\ of\\ the\\ ureters\\ into\\ the\\ bladder\\ or\\ endoscopic\\ injection\\ of\\ copolymer\\ beneath\\ the\\ uvj\\ mucosa\\.\\ \ \(0\)\
\-\ long\\-term\\ complications\\ include\\ chronic\\ pyelonephritis\\ and\\ renal\\ scarring\\ secondary\\ to\\ recurrent\\ infections\\,\\ hypertension\\,\\ proteinuria\\,\\ decreased\\ renal\\ function\\,\\ and\\ esrd\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ vur\\:\\ 0\\.09844980011815392\ \(0\)\
\-\ reflux\\:\\ 0\\.06286598683934579\ \(0\)\
\-\ collecting\\:\\ 0\\.041667240073690985\ \(0\)\
\-\ grade\\:\\ 0\\.04146288908217797\ \(0\)\
\-\ system\\:\\ 0\\.03750216527516813\ \(0\)\
\-\ ureteral\\:\\ 0\\.031903540982141265\ \(0\)\
\-\ ureter\\:\\ 0\\.02936831722659575\ \(0\)\
\-\ bladder\\:\\ 0\\.027614736411218387\ \(0\)\
\-\ \\:\\:\\ 0\\.026997009936082766\ \(0\)\
\-\ vcug\\:\\ 0\\.026367905531666413\ \(0\)\
\-\ infections\\:\\ 0\\.025872154349427606\ \(0\)\
\-\ intravesical\\:\\ 0\\.025867424342059086\ \(0\)\
\-\ prophylactic\\:\\ 0\\.0251282023685211\ \(0\)\
\-\ long\\-term\\:\\ 0\\.02255337832043502\ \(0\)\
\-\ newborns\\:\\ 0\\.02187773335958976\ \(0\)\
\-\ uvj\\:\\ 0\\.020438290290344358\ \(0\)\
\-\ urine\\:\\ 0\\.019701451632503288\ \(0\)\
\-\ calyceal\\:\\ 0\\.019450535741606014\ \(0\)\
\-\ dilation\\:\\ 0\\.01924216567444802\ \(0\)\
\-\ urinary\\:\\ 0\\.018896684807029423\ \(0\)\
\-\ blunting\\:\\ 0\\.018230815193019688\ \(0\)\
\-\ calyces\\:\\ 0\\.01808924907018264\ \(0\)\
\-\ tract\\:\\ 0\\.018081594757519408\ \(0\)\
\-\ mild\\:\\ 0\\.017916030684165102\ \(0\)\
\-\ uti\\:\\ 0\\.017243060644281345\ \(0\)\
\-\ caused\\:\\ 0\\.017122976785566454\ \(0\)\
\-\ urethral\\:\\ 0\\.017037523952760418\ \(0\)\
\-\ valves\\:\\ 0\\.017037523952760418\ \(0\)\
\-\ age\\:\\ 0\\.01656630780601469\ \(0\)\
\-\ resolve\\:\\ 0\\.01609655512188833\ \(0\)\
\-\ repeated\\:\\ 0\\.015746233799549706\ \(0\)\
\-\ w\\/o\\:\\ 0\\.015371128590452943\ \(0\)\
\-\ secondary\\:\\ 0\\.015216751379036992\ \(0\)\
\-\ presence\\:\\ 0\\.01481744722192896\ \(0\)\
\-\ obstruction\\:\\ 0\\.014395223162051442\ \(0\)\
\-\ \\=\\:\\ 0\\.014282755043567413\ \(0\)\
\-\ w\\/\\:\\ 0\\.014119400602842728\ \(0\)\
\-\ \\-r\\:\\ 0\\.014037449719691878\ \(0\)\
\-\ \\-l\\:\\ 0\\.014037449719691878\ \(0\)\
\-\ hyperechogenecity\\:\\ 0\\.014037449719691878\ \(0\)\
\-\ 4yo\\:\\ 0\\.014037449719691878\ \(0\)\
\-\ 5lb\\:\\ 0\\.014037449719691878\ \(0\)\
\-\ 2\\.5wks\\:\\ 0\\.014037449719691878\ \(0\)\
\-\ 2wks\\:\\ 0\\.014037449719691878\ \(0\)\
\-\ vesioureteral\\:\\ 0\\.014037449719691878\ \(0\)\
\-\ 3\\:1\\:\\ 0\\.014037449719691878\ \(0\)\
\-\ appox\\:\\ 0\\.014037449719691878\ \(0\)\
\-\ 4\\-5yo\\:\\ 0\\.014037449719691878\ \(0\)\
\-\ anomaly\\:\\ 0\\.013473092182471103\ \(0\)\
\-\ x\\:\\ 0\\.013466877398156737\ \(0\)\
\-\ 11\\.5cm\\:\\ 0\\.012933712171029543\ \(0\)\
\-\ puv\\:\\ 0\\.012933712171029543\ \(0\)\
\-\ cvat\\:\\ 0\\.012933712171029543\ \(0\)\
\-\ 30\\-45\\:\\ 0\\.012933712171029543\ \(0\)\
\-\ iii\\-v\\:\\ 0\\.012933712171029543\ \(0\)\
\-\ copolymer\\:\\ 0\\.012933712171029543\ \(0\)\
\-\ such\\:\\ 0\\.012761143900513625\ \(0\)\
\-\ \\%\\:\\ 0\\.012696312314305782\ \(0\)\
\-\ despite\\:\\ 0\\.01264755203027996\ \(0\)\
\-\ regular\\:\\ 0\\.01254879331453932\ \(0\)\
\-\ urologic\\:\\ 0\\.012288067094424185\ \(0\)\
\-\ renal\\:\\ 0\\.012265010586583133\ \(0\)\
\-\ there\\:\\ 0\\.012150148628646388\ \(0\)\
\-\ 9\\.5cm\\:\\ 0\\.01182997462236721\ \(0\)\
\-\ demonstrating\\:\\ 0\\.011813926592566618\ \(0\)\
\-\ children\\:\\ 0\\.011756542817080379\ \(0\)\
\-\ ii\\:\\ 0\\.011737642385488615\ \(0\)\
\-\ recurrent\\:\\ 0\\.011484179207404705\ \(0\)\
\-\ massively\\:\\ 0\\.011474650496070698\ \(0\)\
\-\ by\\:\\ 0\\.011328589993987856\ \(0\)\
\-\ 2d\\:\\ 0\\.011184329545761852\ \(0\)\
\-\ standardized\\:\\ 0\\.011184329545761852\ \(0\)\
\-\ grades\\:\\ 0\\.011184329545761852\ \(0\)\
\-\ nitrites\\:\\ 0\\.01093886667979488\ \(0\)\
\-\ ureterovesical\\:\\ 0\\.01093886667979488\ \(0\)\
\-\ cystogram\\:\\ 0\\.01093886667979488\ \(0\)\
\-\ esrd\\:\\ 0\\.01093886667979488\ \(0\)\
\-\ measuring\\:\\ 0\\.010883298479136133\ \(0\)\
\-\ complications\\:\\ 0\\.01078398979303203\ \(0\)\
\-\ 2\\:1\\:\\ 0\\.010726237073704877\ \(0\)\
\-\ evidence\\:\\ 0\\.01070275119442776\ \(0\)\
\-\ race\\:\\ 0\\.010370912947408365\ \(0\)\
\-\ reimplantation\\:\\ 0\\.010370912947408365\ \(0\)\
\-\ \\(\\:\\ 0\\.01035231773279418\ \(0\)\
\-\ \\)\\:\\ 0\\.0102258586449359\ \(0\)\
\-\ antibiotics\\:\\ 0\\.010222026616785035\ \(0\)\
\-\ grading\\:\\ 0\\.010219145145172179\ \(0\)\
\-\ tortuosity\\:\\ 0\\.010080591997099519\ \(0\)\
\-\ compound\\:\\ 0\\.010080591997099519\ \(0\)\
\-\ trigone\\:\\ 0\\.010080591997099519\ \(0\)\
\-\ proteinuria\\:\\ 0\\.010080591997099519\ \(0\)\
\-\ increased\\:\\ 0\\.009986392269743578\ \(0\)\
\-\ involvement\\:\\ 0\\.009974326931935722\ \(0\)\
\-\ iv\\:\\ 0\\.009931289609748706\ \(0\)\
\-\ dilated\\:\\ 0\\.00988882613564213\ \(0\)\
\-\ risk\\:\\ 0\\.009857346010697729\ \(0\)\
\-\ epidemiology\\:\\ 0\\.009835129131132547\ \(0\)\
\-\ esterase\\:\\ 0\\.009725267870803007\ \(0\)\
\-\ shortened\\:\\ 0\\.009725267870803007\ \(0\)\
\-\ radionuclide\\:\\ 0\\.009725267870803007\ \(0\)\
\-\ beneath\\:\\ 0\\.009725267870803007\ \(0\)\
\-\ into\\:\\ 0\\.00971334252210051\ \(0\)\
\-\ u\\/s\\:\\ 0\\.009622499525042544\ \(0\)\
\-\ 104\\:\\ 0\\.009622499525042544\ \(0\)\
\-\ discovery\\:\\ 0\\.009622499525042544\ \(0\)\
\-\ kidney\\:\\ 0\\.00958720845557328\ \(0\)\
\-\ or\\:\\ 0\\.009568688684366632\ \(0\)\
\-\ voiding\\:\\ 0\\.009525963503041851\ \(0\)\
\-\ international\\:\\ 0\\.009525963503041851\ \(0\)\
\-\ most\\:\\ 0\\.00942437169615323\ \(0\)\
\-\ leukocyte\\:\\ 0\\.009348852619108373\ \(0\)\
\-\ characteristically\\:\\ 0\\.009348852619108373\ \(0\)\
\-\ are\\:\\ 0\\.009274473507401288\ \(0\)\
\-\ limit\\:\\ 0\\.00926717539874603\ \(0\)\
\-\ poles\\:\\ 0\\.00926717539874603\ \(0\)\
\-\ categories\\:\\ 0\\.00926717539874603\ \(0\)\
\-\ ureterocele\\:\\ 0\\.00918948405452719\ \(0\)\
\-\ gender\\:\\ 0\\.009115407596509844\ \(0\)\
\-\ longstanding\\:\\ 0\\.00904462453509132\ \(0\)\
\-\ initial\\:\\ 0\\.009017777526367224\ \(0\)\
\-\ urethra\\:\\ 0\\.008849397907555758\ \(0\)\
\-\ dysuria\\:\\ 0\\.008849397907555758\ \(0\)\
\-\ elongated\\:\\ 0\\.008789301843888805\ \(0\)\
\-\ describe\\:\\ 0\\.008789301843888805\ \(0\)\
\-\ definition\\:\\ 0\\.008621530322140672\ \(0\)\
\-\ surgical\\:\\ 0\\.008580677246424142\ \(0\)\
\-\ found\\:\\ 0\\.008576514695707364\ \(0\)\
\-\ divided\\:\\ 0\\.008569317228473492\ \(0\)\
\-\ tortuous\\:\\ 0\\.008518761976380209\ \(0\)\
\-\ f\\/u\\:\\ 0\\.008469762519904488\ \(0\)\
\-\ passage\\:\\ 0\\.008469762519904488\ \(0\)\
\-\ urology\\:\\ 0\\.008422225954379518\ \(0\)\
\-\ opening\\:\\ 0\\.008422225954379518\ \(0\)\
\-\ be\\:\\ 0\\.008393354925757511\ \(0\)\
\-\ ureters\\:\\ 0\\.008376067456173702\ \(0\)\
\-\ vesicoureteral\\:\\ 0\\.008331209371831828\ \(0\)\
\-\ established\\:\\ 0\\.008331209371831828\ \(0\)\
\-\ describes\\:\\ 0\\.008287580432041837\ \(0\)\
\-\ treatment\\:\\ 0\\.008262501399367295\ \(0\)\
\-\ retrograde\\:\\ 0\\.008163437850083697\ \(0\)\
\-\ decreased\\:\\ 0\\.008091580900396687\ \(0\)\
\-\ primary\\:\\ 0\\.008061733321323874\ \(0\)\
\-\ is\\:\\ 0\\.008058307333539062\ \(0\)\
\-\ endoscopic\\:\\ 0\\.008011670047847511\ \(0\)\
\-\ appetite\\:\\ 0\\.007975885245535316\ \(0\)\
\-\ younger\\:\\ 0\\.007940886986428987\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.007940886986428987\ \(0\)\
\-\ scarring\\:\\ 0\\.007940886986428987\ \(0\)\
\-\ infants\\:\\ 0\\.007906641436714077\ \(0\)\
\-\ febrile\\:\\ 0\\.007840283639897885\ \(0\)\
\-\ two\\:\\ 0\\.007794048527439509\ \(0\)\
\-\ tachycardia\\:\\ 0\\.007745660358893424\ \(0\)\
\-\ work\\-up\\:\\ 0\\.0076855642952264715\ \(0\)\
\-\ longer\\:\\ 0\\.0076855642952264715\ \(0\)\
\-\ spontaneously\\:\\ 0\\.0076855642952264715\ \(0\)\
\-\ reduce\\:\\ 0\\.0076855642952264715\ \(0\)\
\-\ childhood\\:\\ 0\\.007656345921550999\ \(0\)\
\-\ functional\\:\\ 0\\.007491472228970043\ \(0\)\
\-\ v\\:\\ 0\\.007465579679811158\ \(0\)\
\-\ consists\\:\\ 0\\.007465579679811158\ \(0\)\
\-\ severity\\:\\ 0\\.007390336232596912\ \(0\)\
\-\ echogenicity\\:\\ 0\\.007318488405717184\ \(0\)\
\-\ impression\\:\\ 0\\.007272329907511368\ \(0\)\
\-\ mucosa\\:\\ 0\\.007183842883379503\ \(0\)\
\-\ grossly\\:\\ 0\\.0071413775217837065\ \(0\)\
\-\ african\\:\\ 0\\.007100015282288068\ \(0\)\
\-\ f\\:\\ 0\\.007100015282288068\ \(0\)\
\-\ group\\:\\ 0\\.007079730209394072\ \(0\)\
\-\ diarrhea\\:\\ 0\\.007059700301421364\ \(0\)\
\-\ m\\:\\ 0\\.00702038085462141\ \(0\)\
\-\ antibiotic\\:\\ 0\\.0069631642794206715\ \(0\)\
\-\ papillary\\:\\ 0\\.006907932499185178\ \(0\)\
\-\ \\,\\:\\ 0\\.00689707173292452\ \(0\)\
\-\ anatomic\\:\\ 0\\.006872147696872983\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.006854552416321096\ \(0\)\
\-\ prevent\\:\\ 0\\.006752878097871204\ \(0\)\
\-\ definitive\\:\\ 0\\.006720379894636797\ \(0\)\
\-\ discovered\\:\\ 0\\.006704376175124852\ \(0\)\
\-\ lab\\:\\ 0\\.006657308018689272\ \(0\)\
\-\ options\\:\\ 0\\.00661159128957712\ \(0\)\
\-\ upper\\:\\ 0\\.0065671353674163005\ \(0\)\
\-\ pediatric\\:\\ 0\\.006552608372888666\ \(0\)\
\-\ ectopic\\:\\ 0\\.006523916485145547\ \(0\)\
\-\ caucasian\\:\\ 0\\.006495732445178349\ \(0\)\
\-\ american\\:\\ 0\\.0064818253114701406\ \(0\)\
\-\ visible\\:\\ 0\\.006440818152071391\ \(0\)\
\-\ normal\\:\\ 0\\.006399422553817362\ \(0\)\
\-\ iii\\:\\ 0\\.006387734680307709\ \(0\)\
\-\ injection\\:\\ 0\\.00634905204882834\ \(0\)\
\-\ and\\:\\ 0\\.0063060479715108374\ \(0\)\
\-\ posterior\\:\\ 0\\.0062727342315364604\ \(0\)\
\-\ diagnosis\\:\\ 0\\.006249106148982229\ \(0\)\
\-\ incidence\\:\\ 0\\.006238341757986604\ \(0\)\
\-\ l\\:\\ 0\\.006203085188118429\ \(0\)\
\-\ r\\:\\ 0\\.006180007151012431\ \(0\)\
\-\ as\\:\\ 0\\.006174733308411438\ \(0\)\
\-\ can\\:\\ 0\\.0061726826511753815\ \(0\)\
\-\ healthy\\:\\ 0\\.006134830881698393\ \(0\)\
\-\ factors\\:\\ 0\\.006112714461060389\ \(0\)\
\-\ open\\:\\ 0\\.006048150616483398\ \(0\)\
\-\ 60\\:\\ 0\\.005936181669958781\ \(0\)\
\-\ young\\:\\ 0\\.0059263825209549936\ \(0\)\
\-\ additionally\\:\\ 0\\.005897341776448973\ \(0\)\
\-\ intermittent\\:\\ 0\\.005840802463619499\ \(0\)\
\-\ via\\:\\ 0\\.005840802463619499\ \(0\)\
\-\ \\-\\:\\ 0\\.005833530123275044\ \(0\)\
\-\ cortex\\:\\ 0\\.005822393510751544\ \(0\)\
\-\ function\\:\\ 0\\.00576841014821065\ \(0\)\
\-\ previously\\:\\ 0\\.005716197054543467\ \(0\)\
\-\ increase\\:\\ 0\\.005707658928522152\ \(0\)\
\-\ junction\\:\\ 0\\.005699166339389409\ \(0\)\
\-\ i\\:\\ 0\\.0056247049287078184\ \(0\)\
\-\ presenting\\:\\ 0\\.005545859284555938\ \(0\)\
\-\ results\\:\\ 0\\.005492901925071094\ \(0\)\
\-\ considered\\:\\ 0\\.005492901925071094\ \(0\)\
\-\ made\\:\\ 0\\.005420178936483214\ \(0\)\
\-\ currently\\:\\ 0\\.005391994896516015\ \(0\)\
\-\ in\\:\\ 0\\.005368117581404521\ \(0\)\
\-\ hypertension\\:\\ 0\\.005364301038694567\ \(0\)\
\-\ 4\\.\\:\\ 0\\.005357452182166876\ \(0\)\
\-\ moderate\\:\\ 0\\.0053506326570203775\ \(0\)\
\-\ pressure\\:\\ 0\\.005343842213092897\ \(0\)\
\-\ reveals\\:\\ 0\\.005323642914482522\ \(0\)\
\-\ the\\:\\ 0\\.005283412154278693\ \(0\)\
\-\ process\\:\\ 0\\.005238957778399227\ \(0\)\
\-\ vomiting\\:\\ 0\\.005195157387014141\ \(0\)\
\-\ based\\:\\ 0\\.005188997392144842\ \(0\)\
\-\ 50\\:\\ 0\\.005176748434146186\ \(0\)\
\-\ a\\:\\ 0\\.005052226774759252\ \(0\)\
\-\ could\\:\\ 0\\.005019996725844828\ \(0\)\
\-\ abnormalities\\:\\ 0\\.004998032837099071\ \(0\)\
\-\ congenital\\:\\ 0\\.004976367786054837\ \(0\)\
\-\ wbc\\:\\ 0\\.004960310271617535\ \(0\)\
\-\ weight\\:\\ 0\\.004877302205638321\ \(0\)\
\-\ of\\:\\ 0\\.004823405765521814\ \(0\)\
\-\ for\\:\\ 0\\.004644000946768886\ \(0\)\
\-\ does\\:\\ 0\\.004642708710802558\ \(0\)\
\-\ inferior\\:\\ 0\\.0046167457983424575\ \(0\)\
\-\ fever\\:\\ 0\\.0046039213798598185\ \(0\)\
\-\ recent\\:\\ 0\\.0045743933898722885\ \(0\)\
\-\ cases\\:\\ 0\\.004533138318441294\ \(0\)\
\-\ \\>\\:\\ 0\\.004520967380045485\ \(0\)\
\-\ study\\:\\ 0\\.004477119994999935\ \(0\)\
\-\ superior\\:\\ 0\\.004345133275563999\ \(0\)\
\-\ should\\:\\ 0\\.004337911690905733\ \(0\)\
\-\ past\\:\\ 0\\.004323566038131265\ \(0\)\
\-\ will\\:\\ 0\\.004257135379584621\ \(0\)\
\-\ approximately\\:\\ 0\\.004209900997699973\ \(0\)\
\-\ clinical\\:\\ 0\\.00418679904469109\ \(0\)\
\-\ medical\\:\\ 0\\.00418679904469109\ \(0\)\
\-\ during\\:\\ 0\\.004164027468031541\ \(0\)\
\-\ only\\:\\ 0\\.004091419838351809\ \(0\)\
\-\ to\\:\\ 0\\.004080268552003053\ \(0\)\
\-\ from\\:\\ 0\\.004033234755268193\ \(0\)\
\-\ evaluation\\:\\ 0\\.003952609547494917\ \(0\)\
\-\ loss\\:\\ 0\\.003949783714121719\ \(0\)\
\-\ when\\:\\ 0\\.0038970242637197546\ \(0\)\
\-\ time\\:\\ 0\\.0038433140561135552\ \(0\)\
\-\ likely\\:\\ 0\\.0038380413470313003\ \(0\)\
\-\ chronic\\:\\ 0\\.0038327860396608284\ \(0\)\
\-\ include\\:\\ 0\\.0038171233885832593\ \(0\)\
\-\ high\\:\\ 0\\.003723799460313401\ \(0\)\
\-\ if\\:\\ 0\\.003692266614300375\ \(0\)\
\-\ therapy\\:\\ 0\\.003637963051338556\ \(0\)\
\-\ common\\:\\ 0\\.003560935050885983\ \(0\)\
\-\ on\\:\\ 0\\.0034580780845482233\ \(0\)\
\-\ bilateral\\:\\ 0\\.003302257530755484\ \(0\)\
\-\ 1\\:\\ 0\\.0032377808407001705\ \(0\)\
\-\ without\\:\\ 0\\.003203842621589427\ \(0\)\
\-\ present\\:\\ 0\\.0030732623470249697\ \(0\)\
\-\ left\\:\\ 0\\.0030449212397226583\ \(0\)\
\-\ presents\\:\\ 0\\.0027796883686431943\ \(0\)\
\-\ no\\:\\ 0\\.002740267995871981\ \(0\)\
\-\ also\\:\\ 0\\.0026825152765448273\ \(0\)\
\-\ has\\:\\ 0\\.00255525473008643\ \(0\)\
\-\ which\\:\\ 0\\.0025400391516601094\ \(0\)\
\-\ male\\:\\ 0\\.002460518372432282\ \(0\)\
\-\ that\\:\\ 0\\.0023502877843293367\ \(0\)\
\-\ not\\:\\ 0\\.001966271770289706\ \(0\)\
\-\ an\\:\\ 0\\.0018816319494979776\ \(0\)\
\-\ history\\:\\ 0\\.001879322512272426\ \(0\)\
\-\ at\\:\\ 0\\.0018435718994134285\ \(0\)\
\-\ \\.\\:\\ 0\\.0015262539404910021\ \(0\)\
\-\ right\\:\\ 0\\.0014357192820229567\ \(0\)\
\-\ patient\\:\\ 0\\.0013639998899942485\ \(0\)\
\-\ with\\:\\ 0\\.000931561911543708\ \(0\)\
